[1] |
马丽媛, 吴亚哲, 王 文, 等. 《中国心血管病报告2017》要点解读[J]. 中国心血管杂志, 2018, 23(1): 3-6.
|
[2] |
Chernyavskiy I, Veeranki S, Sen U, et al. Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise[J]. Ann N Y Acad Sci, 2016, 1363: 138-154.
|
[3] |
Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis[J]. Circ Res, 2016, 118(4): 692-702.
|
[4] |
周昌钻, 潘孙雷, 林 辉, 等. 瑞舒伐他汀对同型半胱氨酸诱导的小鼠血管平滑肌细胞去分化和内质网应激的影响及其机制研究[J]. 中国应用生理学杂志, 2018, 34(1): 43-48.
|
[5] |
Durham AL, Speer MY, Scatena M, et al. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness[J]. Cardiovasc Res, 2018, 114(4): 590-600.
|
[6] |
Yu K, Zheng B, Han M, et al. ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements[J]. Cardiovasc Res, 2011, 90(3): 464-474.
|
[7] |
Wei S, Huang J, Li Y, et al. Novel zinc finger transcription factor ZFP580 promotes differentiation of bone marrow-derived endothelial progenitor cells into endothelial cells via eNOS/NO pathway[J]. J Mol Cell Cardiol, 2015, 87: 17-26.
|
[8] |
Sun HY, Wei SP, Xu RC, et al. Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis[J]. Biochem Biophys Res Commun, 2010, 395(3): 361-366.
|
[9] |
Brown BA, Williams H, George SJ. Evidence for the involvement of matrix-degrading metalloproteinases (MMPs) in atherosclerosis[J]. Prog Mol Biol Transl Sci, 2017, 147: 197-237.
|
[10] |
Belo VA, Guimaraes DA, Castro MM. Matrix metalloproteinase 2 as a potential mediator of vascular smooth muscle cell migration and chronic vascular remodeling in hypertension[J]. J Vasc Res, 2015, 52(4): 221-231.
|
[11] |
Li M, Qian M, Kyler K, et al. Endothelial-vascular smooth muscle cells interactions in atherosclerosis[J]. Front Cardiovasc Med, 2018, 5: 151.
|
[12] |
Li M, Liu Q, Lei J, et al. MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1[J]. Biochem Biophys Res Commun, 2017, 493(1): 270-276.
|
[13] |
Zhang X, Shi H, Wang Y, et al. Down-regulation of hsa-miR-148b inhibits vascular smooth muscle cells proliferation and migration by directly targeting HSP90 in atherosclerosis[J]. Am J Transl Res, 2017, 9(2): 629-637.
|
[14] |
van Gils N, HJMP V, Smit L. Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation[J]. Exp Hematol, 2017, 52: 12-23.
|
[15] |
Ding M, Weng XQ, Sheng Y, et al. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK[J]. Food Chem Toxicol, 2018, 119: 464-478.
|
[16] |
Weng XQ, Sheng Y, Ge DZ, et al. RAF-1/MEK/ERK pathway regulates ATRA-induced differentiation in acute promyelocytic leukemia cells through C/EBPβ, C/EBPε and PU.1[J]. Leuk Res, 2016, 45: 68-74.
|
[17] |
Shi L, Ji Y, Jiang X, et al. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways[J]. Cardiovasc Diabetol, 2015, 14: 18.
|